VAERS 2397081
MERCK & CO. INC. · ROTAVIRUS (ROTATEQ) · Charge U021367
- Staat
- TX
- Alter
- 0,5
- Geschlecht
- U
- Eingang
- 30.07.2022
- Impfdatum
- 26.07.2022
- Beginn
- 26.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Symptomtext
No additional AEs were reported.; Physician reported that a patient received the first dose of ROTATEQ later than recommended. The patient received the first dose of ROTATEQ today 7/26/2022 and the patient was 6 month old.; This spontaneous report was received from a physician and refers to a 6-month-old patient of unknown gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 26-JUL-2022, the 6-month-old patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 dose, lot # reported as: U021367 upon internal validation was confirmed as valid, expiration date was reported: 07-MAR-2023 and was confirmed as valid (exact dose, strength, formulation and route of administration were not provided) for prophylaxis (product administered to patient of inappropriate age). There was no additional adverse event reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
